Valuation
GRDNGuardian Pharmacy Services Inc.
StockNYSEUnited StatesHealth careEU retail investors: available
+3.0% today · +47.7% over a year
No score: too little data.
Stability: among the best of its peers. No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | GRDN | Sector median | vs median |
|---|---|---|---|
| P/E | — | 31.3 · n=152 | — |
| P/B | — | 4.1 · n=304 | — |
| P/S | — | 4.5 · n=298 | — |
| EV/EBIT | — | 27.6 · n=140 | — |
| Free-cash-flow yield | — | 1.4% · n=289 | — |
| Dividend yield | 0.00% | 0.00% · n=361 | — |
| Return on equity | 30.1% | −2.8% · n=305 | — |
| Return on invested capital | — | −0.1% · n=277 | — |
| Gross margin | 21.6% | 62.4% · n=204 | 65% below |
| Net debt / EBITDA | — | 1.33 · n=147 | — |
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 48.4 | 33.1 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 41.3 | 8.2 | — | 3.1% | 1.9% | 8/10 |
| ABBVAbbVie | 50.6 | — | 27.8 | 3.6% | 2.9% | 6/10 |
| MRKMerck | 151.1 | 8.3 | — | 4.0% | 2.3% | 8/10 |
| UNHUnitedHealth | 23.1 | 3.5 | 17.5 | 6.2% | 2.2% | 10/10 |
| TMOThermo Fisher Scientific | 37.0 | 4.8 | 35.0 | 2.9% | 0.3% | 9/10 |
| AMGNAmgen | 27.6 | 18.0 | 23.8 | 3.7% | 2.1% | 9/10 |
| GILDGilead Sciences | — | 16.6 | — | 6.4% | 1.9% | 5/10 |
| ABTAbbott | 42.6 | 3.9 | 34.2 | 3.4% | 2.7% | 6/10 |
| PFEPfizer | 43.5 | 2.0 | — | 6.7% | 7.0% | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 06 Aug 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.